Inventor · disambiguated record
Sevgi Gurkan
Also filed as: GURKAN SEVGI
3 granted patents·5 pending applications·3 citations·filing 2022–2024
58Inventor score
Files withPERFUSE THERAPEUTICS INC8
Top patents by PatentIndex Score
8 records- 0188US11738007B2Treatment of glaucoma using endothelin receptor antagonistsPERFUSE THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·2 cites·11 claims
- 0282US11786510B2Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·1 cites·4 claims
- 0379US2025099435A1Treatment of diabetic retinopathy using endothelin receptor antagonistsPERFUSE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0474US2024189288A1Treatment of glaucoma using endothelin receptor antagonistsPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0570US11873279B2Compositions for treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2022·Granted Jan 16, 2024·0 cites·20 claims
- 0669US2024109876A1Compositions for treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0764US2023414577A1Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseasesPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0853US2024058265A1Treatment of ocular diseases using endothelin receptor antagonistsPERFUSE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sevgi Gurkan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →